Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma
Glaucoma is the leading cause of irreversible blindness worldwide, and pathologically elevated intraocular pressure (IOP) is the major risk factor. Neuroprotection is one of the potential therapies for glaucomatous retinal damage. Intravitreal mesenchymal stem cell (MSC) transplantation provides a v...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/423575dd41ed454da55d0417d8051795 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:423575dd41ed454da55d0417d8051795 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:423575dd41ed454da55d0417d80517952021-11-08T02:35:37ZHuman Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma1687-967810.1155/2021/8852517https://doaj.org/article/423575dd41ed454da55d0417d80517952021-01-01T00:00:00Zhttp://dx.doi.org/10.1155/2021/8852517https://doaj.org/toc/1687-9678Glaucoma is the leading cause of irreversible blindness worldwide, and pathologically elevated intraocular pressure (IOP) is the major risk factor. Neuroprotection is one of the potential therapies for glaucomatous retinal damage. Intravitreal mesenchymal stem cell (MSC) transplantation provides a viable therapeutic option, and human umbilical cord- (hUC-) MSCs are attractive candidates for cell-based neuroprotection. Here, we investigated the ability of transplanted hUC-MSCs to survive and migrate within the vitreous cavity and their neuroprotective effects on chronic glaucomatous retina. For this, we developed a chronic ocular hypertension (COH) rat model through the intracameral injection of allogeneic Tenon’s fibroblasts. Green fluorescent protein-transduced hUC-MSCs were then injected into the vitreous cavity one week after COH induction. Results showed that a moderate IOP elevation lasted for two months. Transplanted hUC-MSCs migrated toward the area of damaged retina, but did not penetrate into the retina. The hUC-MSCs survived for at least eight weeks in the vitreous cavity. Moreover, the hUC-MSCs were efficient at decreasing the loss of retinal ganglion cells; retinal damage was attenuated through the inhibition of apoptosis. In this study, we have developed a novel COH rat model and demonstrated the prolonged neuroprotective potential of intravitreal hUC-MSCs in chronic glaucoma.Yao WangJiexuan LvChangquan HuangXiaohong LiYongxiong ChenWutian WuRenyi WuHindawi LimitedarticleInternal medicineRC31-1245ENStem Cells International, Vol 2021 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Internal medicine RC31-1245 |
spellingShingle |
Internal medicine RC31-1245 Yao Wang Jiexuan Lv Changquan Huang Xiaohong Li Yongxiong Chen Wutian Wu Renyi Wu Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma |
description |
Glaucoma is the leading cause of irreversible blindness worldwide, and pathologically elevated intraocular pressure (IOP) is the major risk factor. Neuroprotection is one of the potential therapies for glaucomatous retinal damage. Intravitreal mesenchymal stem cell (MSC) transplantation provides a viable therapeutic option, and human umbilical cord- (hUC-) MSCs are attractive candidates for cell-based neuroprotection. Here, we investigated the ability of transplanted hUC-MSCs to survive and migrate within the vitreous cavity and their neuroprotective effects on chronic glaucomatous retina. For this, we developed a chronic ocular hypertension (COH) rat model through the intracameral injection of allogeneic Tenon’s fibroblasts. Green fluorescent protein-transduced hUC-MSCs were then injected into the vitreous cavity one week after COH induction. Results showed that a moderate IOP elevation lasted for two months. Transplanted hUC-MSCs migrated toward the area of damaged retina, but did not penetrate into the retina. The hUC-MSCs survived for at least eight weeks in the vitreous cavity. Moreover, the hUC-MSCs were efficient at decreasing the loss of retinal ganglion cells; retinal damage was attenuated through the inhibition of apoptosis. In this study, we have developed a novel COH rat model and demonstrated the prolonged neuroprotective potential of intravitreal hUC-MSCs in chronic glaucoma. |
format |
article |
author |
Yao Wang Jiexuan Lv Changquan Huang Xiaohong Li Yongxiong Chen Wutian Wu Renyi Wu |
author_facet |
Yao Wang Jiexuan Lv Changquan Huang Xiaohong Li Yongxiong Chen Wutian Wu Renyi Wu |
author_sort |
Yao Wang |
title |
Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma |
title_short |
Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma |
title_full |
Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma |
title_fullStr |
Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma |
title_full_unstemmed |
Human Umbilical Cord-Mesenchymal Stem Cells Survive and Migrate within the Vitreous Cavity and Ameliorate Retinal Damage in a Novel Rat Model of Chronic Glaucoma |
title_sort |
human umbilical cord-mesenchymal stem cells survive and migrate within the vitreous cavity and ameliorate retinal damage in a novel rat model of chronic glaucoma |
publisher |
Hindawi Limited |
publishDate |
2021 |
url |
https://doaj.org/article/423575dd41ed454da55d0417d8051795 |
work_keys_str_mv |
AT yaowang humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma AT jiexuanlv humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma AT changquanhuang humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma AT xiaohongli humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma AT yongxiongchen humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma AT wutianwu humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma AT renyiwu humanumbilicalcordmesenchymalstemcellssurviveandmigratewithinthevitreouscavityandameliorateretinaldamageinanovelratmodelofchronicglaucoma |
_version_ |
1718443177445163008 |